SLC3A2 and urinary bladder cancer: Later studies proposed the use of N-butyl-N- (4-hydroxybutyl) nitrosamine (BBN) treatment to induce high expression of LAT1/4F2hc in rat bladder cancer cells [101] and proposed some directions for anti-LAT1/4F2hc drugs.